Clinical Trials Browser

Interventional × RAS Wild Type mCRC × 30 days × Clear all

NCT07490119 2026-03-24

Becotatug Vedotin Combined With Cetuximab in the Later-line Treatment of Metastatic RAS Wild-type Colorectal Cancer

Phase 2 Not yet recruiting

RAS Wild Type mCRC